$snpx

Once in a lifetime (worth the risk)

$SNPX a speculative long with 500x upside and 50% downside.  No joke.

Biotechs are notoriously hard to predict trial outcomes.  $SNPX had trouble in their prior trials as it was a design issue which should have compared excluding a drug some take for Alzheimers and also comparing patients to baseline.  To say the least, the company learned their lessons …